The thromboxane A2 and KATP channel antagonist actions of a series of sulphonylurea derivatives in the pig coronary artery
- 30 April 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 324 (2-3) , 193-200
- https://doi.org/10.1016/s0014-2999(97)00086-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Identification of Microsatellite Markers Near the Human Genes Encoding the β-cell ATP-Sensitive K+ Channel and Linkage Studies with NIDDM in JapaneseDiabetes, 1996
- Prostanoid-induced contractions are blocked by sulfonylureasEuropean Journal of Pharmacology, 1995
- Cloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin SecretionScience, 1995
- Antagonism by lipophilic quaternary ions of the K+ channel opener, levcromakalim, in vascular smooth muscleBritish Journal of Pharmacology, 1994
- POTASSIUM CHANNEL OPENERS AND OTHER REGULATORS OF KATP CHANNELSClinical and Experimental Pharmacology and Physiology, 1994
- EVIDENCE THAT IMIDAZOL(ID)INE‐ AND SULPHONYLUREA‐BASED ANTAGONISTS OF CROMAKALIM ACT AT DIFFERENT SITES IN THE RAT THORACIC AORTAClinical and Experimental Pharmacology and Physiology, 1993
- Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitroBritish Journal of Pharmacology, 1990
- Properties and functions of ATP-sensitive K-channelsCellular Signalling, 1990